Egis Pharmaceuticals PLC, Pharmathen International S.A., Pharmathen S.A.
PolandAll medications by this manufacturer
-
Ropodrin
Form: tablets, prolonged release
Active substance Dosage ropinirole hydrochloride 2.28 mg ATC: N04BC04
-
Ropodrin
Form: tablets, prolonged release
Active substance Dosage ropinirole hydrochloride 4.56 mg ATC: N04BC04
-
Ropodrin
Form: tablets, prolonged release
Active substance Dosage ropinirole hydrochloride 9.121 mg ATC: N04BC04